by [email protected] | May 31, 2023 | Cancer (blood), Cancer (solid tumor), Publication
ABSTRACT Introduction: Chemotherapy-induced nausea and vomiting (CINV) is a recognized adverse outcome among patients with cancer. This retrospective study aimed to quantify the treatment outcomes, resource utilization, and costs associated with antiemetic use to...
by [email protected] | Sep 6, 2022 | Cancer (solid tumor), Publication
Abstract Background: Previous studies report increasing cholangiocarcinoma (CCA) incidence up to 2015. This contemporary retrospective analysis of CCA incidence and mortality in the US from 2001-2017 assessed whether CCA incidence continued to increase beyond...
by [email protected] | Feb 17, 2022 | Cancer (solid tumor), Infectious Disease, Publication
Abstract Introduction Human papillomavirus (HPV) is one of the most common sexually transmitted infection in the United States and can lead to cervical, vulvovaginal, anal, penile, and oropharyngeal cancers. Compared with the general population, US military...
by [email protected] | Nov 4, 2021 | Cancer (solid tumor), Publication
Authors: Daniel J. George, Krishnan Ramaswamy, Ahong Huang, David Russell, Jack Mardekian, Neil M. Schultz, Nora Janjan, Stephen J. Freedland Abstract Background: Black men are more likely to be diagnosed with aggressive prostate cancer (PC) and...
by [email protected] | Nov 4, 2021 | Cancer (solid tumor), Publication
Authors: Stephen J.Freedland, RickardSandin, JanviSah, BirolEmir, QiaoMu, AnnaRatiu, AgnesHong, LucileSerfass, Scott T.Tagawa Abstract Background: Limited real-world data exist on treatment patterns and outcomes in patients with metastatic...
by [email protected] | Jul 20, 2021 | Cancer (solid tumor), Publication
Abstract BACKGROUND: A key therapeutic goal of metastatic renal cell carcinoma (mRCC) treatment is delayed disease progression. The degree to which early therapeutic success affects downstream outcomes is not well established. OBJECTIVE: To assess the clinical and...
